{"meta":{"query_hash":"ae2b6699c4a0","filters":{"venue":"Pharmacogenomics and Personalized Medicine"},"cohort_total":13,"direct_labels_cover":0,"predictions_cover":13,"exported":13,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ae2b6699c4a0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmacogenomics+and+Personalized+Medicine"},"results":[{"id":"W2068587561","doi":"10.2147/pgpm.s6969","title":"The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes","year":2010,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sulfonylurea receptor; Kir6.2; Potassium channel; Medicine; Insulin; Congenital hyperinsulinism; Adenosine triphosphate; Diabetes mellitus; Endocrinology; Internal medicine; Hyperinsulinism; Pharmacology; Mutation; Gene; Biology; Biochemistry; Insulin resistance; Glibenclamide; Protein subunit","score_opus":0.024237500785106374,"score_gpt":0.30279093134175084,"score_spread":0.27855343055664444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068587561","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003912955,0.99211484,0.0005764483,0.00051042106,0.00024746978,0.000017225131,0.00007654888,0.00002488228,0.0025191004],"genre_scores_gemma":[0.014861604,0.9827026,0.0005744363,0.00045919768,0.00021836539,0.000035829344,0.00012666907,0.0000051031666,0.001016236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988055,0.000022781534,0.000025958418,0.000019413535,0.000033457127,0.000017806029],"domain_scores_gemma":[0.99994457,0.000021537882,0.000013960675,0.0000021382004,0.0000125402275,0.0000052408272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019323638,0.0004055657,0.0006148718,0.00071023736,0.00012914793,0.00040546787,0.0005061795,0.0005869625,0.0011090523],"category_scores_gemma":[0.00026113528,0.00012401173,0.00041345463,0.00043889237,0.00019401993,0.00034047023,0.0002952061,0.0006933077,0.00042940737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039149437,0.00020081985,0.0011783066,0.017474376,0.00026423793,0.0030648308,0.00016123422,0.0010501517,0.040348355,0.0078093326,0.015933203,0.9121237],"study_design_scores_gemma":[0.00019699293,0.0010084733,0.010492837,0.0043507856,0.000737658,0.01567213,0.00015811704,0.00075019395,0.024488086,0.0050388724,0.9370359,0.00006995661],"about_ca_topic_score_codex":0.00044370757,"about_ca_topic_score_gemma":0.00091362983,"teacher_disagreement_score":0.0011090523,"about_ca_system_score_codex":0.00045183342,"about_ca_system_score_gemma":0.0003396583,"threshold_uncertainty_score":0.0037102103},"labels":[],"label_agreement":null},{"id":"W2149270596","doi":"10.2147/pgpm.s55339","title":"Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer","year":2014,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Afatinib; Medicine; Epidermal growth factor receptor; T790M; Lung cancer; Adenocarcinoma; EGFR inhibitors; Precision medicine; Drug resistance; Oncology; Targeted therapy; Osimertinib; Cancer research; Gefitinib; Cancer; Erlotinib; Internal medicine; Pathology; Biology","score_opus":0.09332858321314516,"score_gpt":0.4054736549770533,"score_spread":0.31214507176390816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149270596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013047845,0.9974667,0.0003789953,0.0004339386,0.00017524441,0.000007130961,0.00001414514,0.000011334679,0.0013819728],"genre_scores_gemma":[0.0007552629,0.99762493,0.00051521306,0.00030135832,0.00012804382,0.0000072733983,0.000020920646,0.0000016383941,0.0006454108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976295,0.000048818405,0.000027805545,0.000034510867,0.000107387445,0.00001855714],"domain_scores_gemma":[0.9997656,0.000112674956,0.000028737417,0.000010234423,0.000066766996,0.00001605709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007110504,0.0006288835,0.0010652381,0.002206769,0.00027711582,0.00091486075,0.0006364869,0.0011939717,0.002673044],"category_scores_gemma":[0.00054254633,0.00029282348,0.00069988257,0.0021245435,0.00048393995,0.0015203138,0.0006760126,0.0025089572,0.0018952407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047737034,0.000092772876,0.00013560086,0.013286377,0.00011902848,0.00027834877,0.000085150554,0.0006220062,0.0035394267,0.009926025,0.025559083,0.9463083],"study_design_scores_gemma":[0.000016427917,0.00007844545,0.0004579336,0.0020453164,0.000070737005,0.0013027965,0.00004149845,0.00016415978,0.00068039284,0.0036856374,0.99143934,0.000017301372],"about_ca_topic_score_codex":0.0009232567,"about_ca_topic_score_gemma":0.0020728903,"teacher_disagreement_score":0.002673044,"about_ca_system_score_codex":0.0007553516,"about_ca_system_score_gemma":0.00097382534,"threshold_uncertainty_score":0.008942187},"labels":[],"label_agreement":null},{"id":"W2610516495","doi":"10.2147/pgpm.s108123","title":"Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response","year":2017,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Thiopurine methyltransferase; Pharmacogenetics; Medicine; Pharmacogenomics; Mercaptopurine; Azathioprine; Inflammatory bowel disease; Dosing; Disease; Pharmacology; Bioinformatics; Genotype; Internal medicine; Gene; Genetics; Biology","score_opus":0.04623696960721095,"score_gpt":0.36929772150100615,"score_spread":0.3230607518937952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610516495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.067932636,0.9254368,0.0009314118,0.002554445,0.00021148896,0.00003892302,0.0007449735,0.000018851226,0.0021304132],"genre_scores_gemma":[0.44371456,0.54995525,0.0025561466,0.0014498981,0.0007006798,0.00011259397,0.0008593902,0.000016197095,0.0006352717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984347,0.0007903176,0.0002745327,0.00017908364,0.00027332082,0.000047987443],"domain_scores_gemma":[0.9956033,0.0029699688,0.0009823617,0.00006701991,0.00030770383,0.0000695803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002022829,0.0002072162,0.0007255604,0.0006417328,0.000091473754,0.00051809085,0.00024354846,0.0004121287,0.0012166372],"category_scores_gemma":[0.00685353,0.00008056937,0.0007587825,0.0014288512,0.00017501148,0.00026586757,0.00019118213,0.00049848505,0.00017135801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034582876,0.0001332942,0.21341746,0.021886114,0.006557387,0.0006324553,0.00027874313,0.0014948467,0.004458916,0.0010478854,0.0053028413,0.7413319],"study_design_scores_gemma":[0.0006214864,0.0018930347,0.8446394,0.01674514,0.017163329,0.004790735,0.00037088784,0.0018611382,0.0058431593,0.0023401936,0.10364093,0.00009048685],"about_ca_topic_score_codex":0.0008838734,"about_ca_topic_score_gemma":0.0010332911,"teacher_disagreement_score":0.002022829,"about_ca_system_score_codex":0.00038842624,"about_ca_system_score_gemma":0.0005021201,"threshold_uncertainty_score":0.010697901},"labels":[],"label_agreement":null},{"id":"W2792357848","doi":"10.2147/pgpm.s107710","title":"CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment","year":2018,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tacrolimus; CYP3A5; Medicine; Dosing; Pharmacogenetics; Pharmacokinetics; Pharmacology; Genotype; Nephrotoxicity; Therapeutic index; Transplantation; Kidney transplantation; Therapeutic drug monitoring; Toxicity; Internal medicine; Biology; Drug; Genetics","score_opus":0.09235587715868478,"score_gpt":0.4006920713580662,"score_spread":0.30833619419938146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792357848","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939215,0.0035575891,0.00021617775,0.00045303017,0.000052470565,0.0000059275058,0.00021985552,0.000008735,0.001564755],"genre_scores_gemma":[0.99916947,0.00029906165,0.00006264842,0.000077061435,0.000049955008,0.0000022503077,0.00009407458,0.000004048299,0.00024141176],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999587,0.00011244714,0.000047643134,0.00007602382,0.00009621563,0.00008065849],"domain_scores_gemma":[0.99892634,0.00031395472,0.0003883395,0.000050411614,0.00009803743,0.00022288768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005105496,0.00019590936,0.00037594142,0.00033672803,0.0003224442,0.0006041926,0.000246538,0.00053451554,0.0038302399],"category_scores_gemma":[0.0017584555,0.00008309072,0.0009833894,0.0008509317,0.00018879547,0.00025996054,0.00017583778,0.0006960691,0.00046000304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007277768,0.000076841134,0.9896812,0.000035087185,0.00024440704,0.00043968184,0.00006652354,0.000092369635,0.0006267988,0.00006363601,0.00028860543,0.0076571642],"study_design_scores_gemma":[0.000011227111,0.00013222672,0.99748707,0.00002150631,0.00025863465,0.0008406962,0.00007878709,0.00027871144,0.00015405813,0.00007617039,0.0006555415,0.0000052889177],"about_ca_topic_score_codex":0.0019224909,"about_ca_topic_score_gemma":0.0012256689,"teacher_disagreement_score":0.0038302399,"about_ca_system_score_codex":0.0002610524,"about_ca_system_score_gemma":0.00030888827,"threshold_uncertainty_score":0.012813449},"labels":[],"label_agreement":null},{"id":"W2936175924","doi":"10.2147/pgpm.s192924","title":"<p>Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors</p>","year":2019,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Shriners Hospitals for Children - Canada; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; C17 Council; Cancer Research Society; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Medicine; Lymphoblastic Leukemia; Identification (biology); Skeletal muscle; Internal medicine; Pediatrics; Leukemia","score_opus":0.014488146948388701,"score_gpt":0.26590021236836936,"score_spread":0.2514120654199807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936175924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486756,0.0009305271,0.0002700397,0.00056139054,0.000038322465,0.000019218982,0.0011794226,0.00001950591,0.002113959],"genre_scores_gemma":[0.99605536,0.00073446013,0.000609891,0.00020574027,0.00004705785,0.00001942455,0.0012203562,0.0000147851715,0.0010930412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983025,0.000027307646,0.000015102865,0.000039976894,0.000048663365,0.000038646373],"domain_scores_gemma":[0.9996469,0.00007055119,0.00016391977,0.0000137720735,0.000046525365,0.00005830487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021928371,0.00039611422,0.00014904157,0.0005447364,0.0003677762,0.0005414227,0.0003539179,0.00047102035,0.0022450523],"category_scores_gemma":[0.0007817921,0.00010068125,0.00023298274,0.0008683251,0.0002696413,0.00015132377,0.00031615316,0.0003731759,0.00029657313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042588913,0.000058636848,0.96426123,0.00005584793,0.00010104646,0.0023305316,0.00018876883,0.00033095776,0.007056771,0.00026476584,0.0028361743,0.022089416],"study_design_scores_gemma":[0.000048410293,0.0001504347,0.9884615,0.00006423152,0.00010540324,0.00473465,0.0003143376,0.0007612512,0.0019161074,0.00031639994,0.0031148703,0.000012523553],"about_ca_topic_score_codex":0.013385355,"about_ca_topic_score_gemma":0.016551299,"teacher_disagreement_score":0.013385355,"about_ca_system_score_codex":0.00044598724,"about_ca_system_score_gemma":0.0004054,"threshold_uncertainty_score":0.026614904},"labels":[],"label_agreement":null},{"id":"W3019172665","doi":"10.2147/pgpm.s198225","title":"<p>Challenges and Future Prospects of Precision Medicine in Psychiatry</p>","year":2020,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Treatment of Major Depression","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Precision medicine; Psychiatry; Pathology","score_opus":0.05824669392619478,"score_gpt":0.3612625721149344,"score_spread":0.3030158781887396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019172665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112649504,0.9821738,0.0008474956,0.012041133,0.001396997,0.000010941854,0.00007921697,0.00004552007,0.0032923557],"genre_scores_gemma":[0.0017433683,0.9874901,0.0017619497,0.0051790485,0.0021073744,0.00003111646,0.000112567504,0.0000171975,0.0015573744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875915,0.00044697008,0.0001231246,0.00016256417,0.00038300036,0.00012515744],"domain_scores_gemma":[0.99170977,0.005616071,0.00048765732,0.0002847707,0.0015280315,0.00037374208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004361214,0.0006600545,0.001549149,0.002120628,0.00053953077,0.0030049656,0.0012973895,0.0034351414,0.011043168],"category_scores_gemma":[0.0068827965,0.00033140375,0.0011746119,0.002621714,0.0016693496,0.0040503717,0.0016715522,0.004069869,0.004826663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067886576,0.000042957938,0.00018428317,0.016228031,0.00010409984,0.00019585343,0.00012924559,0.00036729264,0.00058672903,0.026696363,0.08378366,0.8716137],"study_design_scores_gemma":[0.000019488703,0.00006373509,0.0005138896,0.00961188,0.00007588316,0.00051092386,0.00013264963,0.00023399574,0.00017822642,0.022180863,0.96644855,0.000030054458],"about_ca_topic_score_codex":0.0023058073,"about_ca_topic_score_gemma":0.003969735,"teacher_disagreement_score":0.011043168,"about_ca_system_score_codex":0.001854554,"about_ca_system_score_gemma":0.005439229,"threshold_uncertainty_score":0.036943078},"labels":[],"label_agreement":null},{"id":"W3068359420","doi":"10.2147/pgpm.s261208","title":"<p>IL-6 −572C>G and CARD8 304T>A Genetic Polymorphisms are Associated with the Absolute Neutrophil Count in Patients with Hematological Malignancies Under Chemotherapy: An Application of Multilevel Models to a Preliminary Pharmacogenetic Study</p>","year":2020,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Population Health Research Institute","funders":"Universidad de Chile","keywords":"Medicine; Internal medicine; Gastroenterology; Chemotherapy; Absolute neutrophil count; Genotype; Neutropenia; Oncology; Acute leukemia; Leukemia; Gene","score_opus":0.03032901294697899,"score_gpt":0.2638131900072627,"score_spread":0.23348417706028374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3068359420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994086,0.00018852796,0.004522012,0.00019407576,0.00001809871,0.00004938279,0.0006463882,0.00002439148,0.00027106504],"genre_scores_gemma":[0.9971433,0.000048029146,0.0019961756,0.000020684047,0.000009597442,0.000056452016,0.0003775977,0.000005520332,0.00034252176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979317,0.0012279364,0.000094440096,0.0004856052,0.00011913109,0.0001411788],"domain_scores_gemma":[0.9950919,0.003250049,0.0008082523,0.000510848,0.00015056678,0.0001883223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029991898,0.0005908467,0.0007623709,0.00060998014,0.00051493774,0.0007498965,0.00092145207,0.00054175255,0.0036866774],"category_scores_gemma":[0.0059155985,0.00029929116,0.0024906415,0.00062803447,0.00034440684,0.00023298852,0.00075172784,0.0009706828,0.0002307112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015652617,0.00016523291,0.9831607,0.000060192375,0.0021565661,0.00020584701,0.00019742305,0.004836741,0.0008078929,0.00043205093,0.00040096842,0.006011258],"study_design_scores_gemma":[0.00035042237,0.0014394396,0.789499,0.00008555654,0.0029446296,0.0005128079,0.00052495126,0.20107165,0.000751917,0.0016232234,0.0011543983,0.00004201771],"about_ca_topic_score_codex":0.013939245,"about_ca_topic_score_gemma":0.008477484,"teacher_disagreement_score":0.013939245,"about_ca_system_score_codex":0.0005326178,"about_ca_system_score_gemma":0.0007286484,"threshold_uncertainty_score":0.02771622},"labels":[],"label_agreement":null},{"id":"W4285684482","doi":"10.2147/pgpm.s348851","title":"The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists","year":2022,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health; University of Alberta","funders":"","keywords":"Pharmacogenomics; Likert scale; Medicine; Pharmacy; Medical education; Scale (ratio); Family medicine; Pharmacology; Psychology","score_opus":0.08072898205224215,"score_gpt":0.43765684782878245,"score_spread":0.3569278657765403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285684482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958989,0.00011429692,0.00019015318,0.00028515418,0.000029089024,0.0010274723,0.000040162493,0.000046706755,0.0023679994],"genre_scores_gemma":[0.9958889,0.00024600973,0.0019098183,0.00016393956,0.00003636549,0.0006533499,0.00008403612,0.0000027259168,0.0010149243],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987656,0.00042827168,0.000065766646,0.00015873247,0.00034281606,0.00023893738],"domain_scores_gemma":[0.9942021,0.0021446731,0.0006477517,0.00026149352,0.00054248614,0.0022015492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022125442,0.00052599807,0.0003423109,0.00062289624,0.00077971746,0.0005588399,0.0012016337,0.0010237952,0.0030050927],"category_scores_gemma":[0.011069378,0.00027777263,0.00037917378,0.0003738031,0.00040071135,0.00045543286,0.0011614962,0.0007913837,0.00023289814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030228209,0.29592806,0.036831237,0.00097608415,0.00017637094,0.0003545315,0.0027245085,0.003657662,0.0028687082,0.00034903619,0.0028052388,0.6231003],"study_design_scores_gemma":[0.049651418,0.2964412,0.6204428,0.00076127454,0.0006780757,0.00039985584,0.0018241015,0.013753169,0.0070070396,0.0006499579,0.008256649,0.00013438676],"about_ca_topic_score_codex":0.03900992,"about_ca_topic_score_gemma":0.04585942,"teacher_disagreement_score":0.9609901,"about_ca_system_score_codex":0.0038018238,"about_ca_system_score_gemma":0.0076722573,"threshold_uncertainty_score":0.07756573},"labels":[],"label_agreement":null},{"id":"W4285744210","doi":"10.2147/pgpm.s350205","title":"The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Erasmus Medisch Centrum","keywords":"Medicine; Pharmacogenetics; Pharmacokinetics; Pharmacodynamics; Pharmacology; Intensive care medicine; Genotype; Genetics","score_opus":0.10503252718016293,"score_gpt":0.46716417868448157,"score_spread":0.36213165150431864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285744210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094229454,0.9978229,0.00013307671,0.00016408662,0.000062544656,0.00016985484,0.00048730712,0.000005836564,0.00021209495],"genre_scores_gemma":[0.012658427,0.98566276,0.00046293018,0.0003870255,0.00006469289,0.0003933734,0.00027359495,0.0000045033303,0.000092689144],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99355423,0.0019271729,0.0028078547,0.0004666824,0.0010627372,0.00018130142],"domain_scores_gemma":[0.97053987,0.023029499,0.0043753744,0.0003460221,0.0015086868,0.00020055292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007158965,0.0012347496,0.0077289273,0.008190218,0.00042124192,0.0020088607,0.0016571247,0.0015578928,0.0040948703],"category_scores_gemma":[0.03160064,0.0007435927,0.007095091,0.011309525,0.00064116524,0.0019746218,0.0012357603,0.00083838956,0.00029949012],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014948794,0.000007290579,0.00077563897,0.96511716,0.0066106417,0.00010846095,0.000110511995,0.00008037643,0.00011588739,0.0001344307,0.0008989036,0.025891146],"study_design_scores_gemma":[0.00021503166,0.00018866366,0.0058001634,0.8897287,0.0855319,0.0005930633,0.00020145447,0.00009388672,0.00017802524,0.00024055662,0.01719717,0.0000313571],"about_ca_topic_score_codex":0.0071482393,"about_ca_topic_score_gemma":0.019423725,"teacher_disagreement_score":0.008190218,"about_ca_system_score_codex":0.0026141366,"about_ca_system_score_gemma":0.008724064,"threshold_uncertainty_score":0.03786069},"labels":[],"label_agreement":null},{"id":"W4308454158","doi":"10.2147/pgpm.s385272","title":"Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis","year":2022,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacogenomics; Opioid; Pharmacogenetics; Adverse effect; Celecoxib; Intensive care medicine; Osteoarthritis; Pharmacotherapy; Physical therapy; Alternative medicine; Pharmacology; Internal medicine","score_opus":0.02345495770120698,"score_gpt":0.27450706786797024,"score_spread":0.25105211016676326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308454158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91845876,0.007943685,0.007281512,0.035426736,0.00026717852,0.00017772737,0.00093788246,0.00019909875,0.029307466],"genre_scores_gemma":[0.986919,0.002745794,0.0052065076,0.0036012426,0.0002386,0.000016456945,0.00015272174,0.000018658286,0.0011010495],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994105,0.00018132293,0.000089101915,0.00006651872,0.00017093307,0.00008160793],"domain_scores_gemma":[0.99898046,0.0005000242,0.00022591751,0.000044352695,0.00015182681,0.000097396725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006283066,0.0003030745,0.00032436659,0.0009770637,0.0006195204,0.0010441581,0.00026441427,0.00076033396,0.0021241666],"category_scores_gemma":[0.0032272728,0.000139557,0.00039959024,0.0007590005,0.0003427681,0.00054123177,0.00041280797,0.0011982323,0.0003759819],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038984598,0.0006694909,0.84233695,0.00022639912,0.000116887335,0.03712604,0.00090444856,0.0010151606,0.0084842695,0.0012403798,0.006704276,0.100785896],"study_design_scores_gemma":[0.000153668,0.002931143,0.6697266,0.0012716408,0.00073484564,0.22378196,0.0051273177,0.023080358,0.023725599,0.012068812,0.03720679,0.00019118],"about_ca_topic_score_codex":0.0034588054,"about_ca_topic_score_gemma":0.006729179,"teacher_disagreement_score":0.0034588054,"about_ca_system_score_codex":0.00046987948,"about_ca_system_score_gemma":0.00074753235,"threshold_uncertainty_score":0.007106006},"labels":[],"label_agreement":null},{"id":"W4360862235","doi":"10.2147/pgpm.s383221","title":"Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation","year":2023,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Von Willebrand factor; Coagulation; Pharmacokinetics; ABO blood group system; Immunology; Dosing; Internal medicine; Pharmacology; Platelet","score_opus":0.3865463992255132,"score_gpt":0.48052116720461024,"score_spread":0.09397476797909704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360862235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009206652,0.99893266,0.00008930238,0.0002774376,0.00006753097,0.0000022475422,0.00001952962,0.000005360458,0.0005137735],"genre_scores_gemma":[0.0007311706,0.9986455,0.00013222861,0.0001565769,0.00008563848,0.000004561319,0.00002731397,9.355485e-7,0.00021615424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997961,0.000035693112,0.000033364962,0.000046140038,0.000071344264,0.00001734423],"domain_scores_gemma":[0.9991026,0.0005652096,0.000105703315,0.000020723046,0.00017013791,0.000035514593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008555032,0.00070985884,0.0012729258,0.0016572815,0.00017996278,0.0009247032,0.00068171404,0.0009554074,0.003968934],"category_scores_gemma":[0.0012579401,0.00021539092,0.0005542905,0.001803684,0.00037262827,0.0010622699,0.00045093952,0.0012256321,0.0014358864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007404201,0.00004907319,0.00030401492,0.018852325,0.00013266744,0.000109256405,0.000039988176,0.00027435512,0.00092997064,0.0029324903,0.01502601,0.96127594],"study_design_scores_gemma":[0.000026062984,0.00011905343,0.0019569409,0.009648581,0.00043795077,0.0014820389,0.000072312374,0.00013799815,0.00051305594,0.0028692852,0.98271435,0.000022448163],"about_ca_topic_score_codex":0.0011658092,"about_ca_topic_score_gemma":0.0012149469,"teacher_disagreement_score":0.003968934,"about_ca_system_score_codex":0.0005047108,"about_ca_system_score_gemma":0.0012041768,"threshold_uncertainty_score":0.013277352},"labels":[],"label_agreement":null},{"id":"W4403836480","doi":"10.2147/pgpm.s481068","title":"Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension","year":2024,"lang":"en","type":"article","venue":"Pharmacogenomics and Personalized Medicine","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Moncton; Centre for Addiction and Mental Health","funders":"King Saud University","keywords":"Medicine; Amlodipine; Pharmacogenomics; Blood pressure; Internal medicine; Pharmacology; Cardiology","score_opus":0.02188692059917152,"score_gpt":0.29058355028663674,"score_spread":0.2686966296874652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403836480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920815,0.000211495,0.00018142839,0.000032218595,0.0000054896564,0.0000056256254,0.00019335028,0.000003439893,0.00015887628],"genre_scores_gemma":[0.99955636,0.00003990817,0.00013727655,0.000015442594,0.0000066187927,0.0000045476977,0.00013107041,0.0000014663154,0.00010725146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997079,0.00008999253,0.000032670716,0.00009459447,0.000043529413,0.000031352134],"domain_scores_gemma":[0.99951994,0.00017441728,0.00016103126,0.00004044495,0.000048532693,0.000055676766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027844027,0.0002070207,0.0003217051,0.00053987466,0.00026487198,0.0003434023,0.0001628654,0.00032143624,0.0014179122],"category_scores_gemma":[0.00089576025,0.00010067444,0.00036766788,0.000853556,0.00012331954,0.00011349165,0.00013630498,0.00028476788,0.00015317282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064750353,0.00008525777,0.989705,0.000025771475,0.00023277117,0.0002674342,0.000113653135,0.00009205922,0.0046508526,0.000034668956,0.000100376434,0.004044609],"study_design_scores_gemma":[0.000012009476,0.00017944096,0.99823296,0.0000036951578,0.00011199759,0.0003514227,0.00007478507,0.00038931213,0.00043070124,0.00004363473,0.00016679049,0.0000032655523],"about_ca_topic_score_codex":0.0010134557,"about_ca_topic_score_gemma":0.001149696,"teacher_disagreement_score":0.0014179122,"about_ca_system_score_codex":0.00010950754,"about_ca_system_score_gemma":0.00014247776,"threshold_uncertainty_score":0.0047433376},"labels":[],"label_agreement":null},{"id":"W4406928370","doi":"10.2147/pgpm.s490135","title":"Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacogenomics; Low and middle income countries; Public health; Precision medicine; Developing country; Pharmacology; Economic growth; Nursing; Pathology","score_opus":0.2597879676768023,"score_gpt":0.4950694151345046,"score_spread":0.2352814474577023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406928370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014966313,0.9947909,0.00077204284,0.0025393304,0.00028856436,0.00013439776,0.00017141772,0.00001698141,0.0011367819],"genre_scores_gemma":[0.0014761452,0.99558663,0.0015804131,0.0007640199,0.00012716306,0.00019885055,0.0001338916,0.000005368755,0.00012754892],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927797,0.0028500266,0.002328551,0.00039734325,0.0014456239,0.0001987898],"domain_scores_gemma":[0.93072337,0.05852974,0.004147112,0.0008778682,0.005312825,0.00040907983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016295008,0.0012790194,0.0032194532,0.0195267,0.0009338345,0.0045524193,0.0020743378,0.0031955133,0.004902006],"category_scores_gemma":[0.0510496,0.00071404537,0.003949828,0.019331286,0.0014351392,0.004453303,0.0025729206,0.0024819544,0.0010092782],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007451626,0.00003873939,0.0005546989,0.49714294,0.0011820663,0.00027738308,0.00076370314,0.00074129226,0.00032752013,0.012344778,0.020914089,0.46563834],"study_design_scores_gemma":[0.00002108391,0.000043220713,0.00083330565,0.7659226,0.002354907,0.00028215314,0.0004085913,0.00025251938,0.00016060633,0.00450879,0.22518435,0.000027891901],"about_ca_topic_score_codex":0.008240906,"about_ca_topic_score_gemma":0.013181418,"teacher_disagreement_score":0.0195267,"about_ca_system_score_codex":0.0050001494,"about_ca_system_score_gemma":0.023274986,"threshold_uncertainty_score":0.08617723},"labels":[],"label_agreement":null}]}